Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AustinPx | Contract Pharma

What are you searching for?

Sign in

Search by

AustinPx

Company Headquarters

111 Cooperative Way, Building 3, Georgetown, TX, 78626, US

Driving Directions Phone: View Phone
View website

Request more information from AustinPx

Request more information from AustinPx

Categories from AustinPx

API Solubilization Technologies
Bioavailability Studies
Clinical Trials, Phase I
Clinical Trials, Phase II
CMC (Chemistry, Manfacturing & Controls)
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Dissolution Testing
Dosage Form Development
Downstream Processing
Drug Development Services
Encapsulation
Formulation Development
Formulation Services
Formulation, Controlled Release
Granulation
Lead Optimization
Manufacturing, Capsules
Manufacturing, Clinical Trials Supply
Manufacturing, Dose Form, Non-Sterile
Manufacturing, Oral Drug Delivery
Manufacturing, Solid Dosage
Manufacturing, Tablets
Methods Validation
Microdosing
Preclinical Study Design
Preclinical Testing
Preclinical Testing Formulations
Preformulation
Process Characterization
Process Development/Scale-Up Services
Process Validation Studies
Scale-Up
Spray Drying
Stability Studies
Stability, ICH
Tablet Coating
Technology Transfer
Pharma Matters Q&A: AustinPx

Pharma Matters Q&A

Pharma Matters Q&A: AustinPx

Talking next-gen amorphous dispersion technology with Dave Miller, Chief Scientific Officer of AustinPx.

Released By AustinPx

Related Content

Breaking News

AustinPx KinetiSol Earns FDA AMT Designation

Solvent-free technology expands manufacturing options for poorly soluble oral drug candidates.

By: Charlie Sternberg